Behavioral characterization of G-protein-coupled receptor 160 knockout mice
- 10 January 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (6) , 1361-1371
Abstract
Neuropathic pain is a devastating condition where current therapeutics offer little to no pain relief. Novel nonnarcotic therapeutic targets are needed to address this growing medical problem. Our work identified the G-protein-coupled receptor 160 (GPR160) as a potential target for therapeutic intervention. However, the lack of small-molecule ligands for GPR160 hampers our understanding of its role in health and disease. To address this void, we generated a global Gpr160 knockout (KO) mouse using CRISPR-Cas9 genome editing technology to validate the contributions of GPR160 in nociceptive behaviors in mice. Gpr160 KO mice are healthy and fertile, with no observable physical abnormalities. Gpr160 KO mice fail to develop behavioral hypersensitivities in a model of neuropathic pain caused by constriction of the sciatic nerve. On the other hand, responses of Gpr160 KO mice in the hot-plate and tail-flick assays are not affected. We recently deorphanized GPR160 and identified cocaine- and amphetamine-regulated transcript peptide (CARTp) as a potential ligand. Using Gpr160 KO mice, we now report that the development of behavioral hypersensitivities after intrathecal or intraplantar injections of CARTp are dependent on GPR160. Cocaine- and amphetamine-regulated transcript peptide plays a role in various affective behaviors, such as anxiety, depression, and cognition. There are no differences in learning, memory, and anxiety between Gpr160 KO mice and their age-matched and sex-matched control floxed mice. Results from these studies support the pronociceptive roles of CARTp/GPR160 and GPR160 as a potential therapeutic target for treatment of neuropathic pain.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS1132257)
This publication has 72 references indexed in Scilit:
- Neurogenic inflammation and the peripheral nervous system in host defense and immunopathologyNature Neuroscience, 2012
- CART peptide stimulation of G protein-mediated signaling in differentiated PC12 Cells: Identification of PACAP 6–38 as a CART receptor antagonistNeuropeptides, 2011
- Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX)Toxins, 2011
- Nonselective innervation of lamina I projection neurons by cocaine‐ and amphetamine‐regulated transcript peptide (CART)‐immunoreactive fibres in the rat spinal dorsal hornEuropean Journal of Neuroscience, 2009
- Cocaine and Amphetamine-Regulated Transcript May Regulate Bone Remodeling as a Circulating MoleculeEndocrinology, 2008
- Neuropathic painNeurology, 2008
- Importance of Cocaine- and Amphetamine-Regulated Transcript Peptide in the Central Nucleus of Amygdala in Anxiogenic Responses Induced by Ethanol WithdrawalNeuropsychopharmacology, 2007
- Cocaine- and amphetamine related transcript (CART) and anxietyPeptides, 2006
- Cocaine- and Amphetamine-Regulated Transcript (CART) Peptides Modulate the Locomotor and Motivational Properties of PsychostimulantsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- A Human Orphan Calcitonin Receptor-like StructureBiochemical and Biophysical Research Communications, 1995